Intellia surges in first trading day

Gene editing company Intellia Therapeutics Inc. (NASDAQ:NTLA) rose $4.10 (23%) to $22.10 in its first day of trading Friday after it raised a combined $163 million in an IPO and concurrent private placements (see BioCentury Extra, May 5). ...